table of content
1 Introduction to Research & Analysis Reports
1.1 Phase I - IV Clinical Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Phase I - IV Clinical Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Phase I - IV Clinical Development Services Overall Market Size
2.1 Global Phase I - IV Clinical Development Services Market Size: 2021 VS 2028
2.2 Global Phase I - IV Clinical Development Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Phase I - IV Clinical Development Services Players in Global Market
3.2 Top Global Phase I - IV Clinical Development Services Companies Ranked by Revenue
3.3 Global Phase I - IV Clinical Development Services Revenue by Companies
3.4 Top 3 and Top 5 Phase I - IV Clinical Development Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Phase I - IV Clinical Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Phase I - IV Clinical Development Services Players in Global Market
3.6.1 List of Global Tier 1 Phase I - IV Clinical Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Phase I - IV Clinical Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Phase I - IV Clinical Development Services Market Size Markets, 2021 & 2028
4.1.2 Early Phase
4.1.3 Phase II-III
4.1.4 Phase IIIb-IV
4.2 By Type - Global Phase I - IV Clinical Development Services Revenue & Forecasts
4.2.1 By Type - Global Phase I - IV Clinical Development Services Revenue, 2017-2022
4.2.2 By Type - Global Phase I - IV Clinical Development Services Revenue, 2023-2028
4.2.3 By Type - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Phase I - IV Clinical Development Services Market Size, 2021 & 2028
5.1.2 Pharmaceutical Companies
5.1.3 Medical Device Companies
5.1.4 Contract Research Organizations
5.2 By Application - Global Phase I - IV Clinical Development Services Revenue & Forecasts
5.2.1 By Application - Global Phase I - IV Clinical Development Services Revenue, 2017-2022
5.2.2 By Application - Global Phase I - IV Clinical Development Services Revenue, 2023-2028
5.2.3 By Application - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Phase I - IV Clinical Development Services Market Size, 2021 & 2028
6.2 By Region - Global Phase I - IV Clinical Development Services Revenue & Forecasts
6.2.1 By Region - Global Phase I - IV Clinical Development Services Revenue, 2017-2022
6.2.2 By Region - Global Phase I - IV Clinical Development Services Revenue, 2023-2028
6.2.3 By Region - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Phase I - IV Clinical Development Services Revenue, 2017-2028
6.3.2 US Phase I - IV Clinical Development Services Market Size, 2017-2028
6.3.3 Canada Phase I - IV Clinical Development Services Market Size, 2017-2028
6.3.4 Mexico Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Phase I - IV Clinical Development Services Revenue, 2017-2028
6.4.2 Germany Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.3 France Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.4 U.K. Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.5 Italy Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.6 Russia Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.7 Nordic Countries Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.8 Benelux Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Phase I - IV Clinical Development Services Revenue, 2017-2028
6.5.2 China Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5.3 Japan Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5.4 South Korea Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5.5 Southeast Asia Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5.6 India Phase I - IV Clinical Development Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Phase I - IV Clinical Development Services Revenue, 2017-2028
6.6.2 Brazil Phase I - IV Clinical Development Services Market Size, 2017-2028
6.6.3 Argentina Phase I - IV Clinical Development Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue, 2017-2028
6.7.2 Turkey Phase I - IV Clinical Development Services Market Size, 2017-2028
6.7.3 Israel Phase I - IV Clinical Development Services Market Size, 2017-2028
6.7.4 Saudi Arabia Phase I - IV Clinical Development Services Market Size, 2017-2028
6.7.5 UAE Phase I - IV Clinical Development Services Market Size, 2017-2028
7 Players Profiles
7.1 Syneos Health
7.1.1 Syneos Health Corporate Summary
7.1.2 Syneos Health Business Overview
7.1.3 Syneos Health Phase I - IV Clinical Development Services Major Product Offerings
7.1.4 Syneos Health Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.1.5 Syneos Health Key News
7.2 PPD
7.2.1 PPD Corporate Summary
7.2.2 PPD Business Overview
7.2.3 PPD Phase I - IV Clinical Development Services Major Product Offerings
7.2.4 PPD Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.2.5 PPD Key News
7.3 GVI CDS
7.3.1 GVI CDS Corporate Summary
7.3.2 GVI CDS Business Overview
7.3.3 GVI CDS Phase I - IV Clinical Development Services Major Product Offerings
7.3.4 GVI CDS Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.3.5 GVI CDS Key News
7.4 Parexel
7.4.1 Parexel Corporate Summary
7.4.2 Parexel Business Overview
7.4.3 Parexel Phase I - IV Clinical Development Services Major Product Offerings
7.4.4 Parexel Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.4.5 Parexel Key News
7.5 Clinical Leader
7.5.1 Clinical Leader Corporate Summary
7.5.2 Clinical Leader Business Overview
7.5.3 Clinical Leader Phase I - IV Clinical Development Services Major Product Offerings
7.5.4 Clinical Leader Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.5.5 Clinical Leader Key News
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Corporate Summary
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Phase I - IV Clinical Development Services Major Product Offerings
7.6.4 Thermo Fisher Scientific Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.6.5 Thermo Fisher Scientific Key News
7.7 LabCorp
7.7.1 LabCorp Corporate Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Phase I - IV Clinical Development Services Major Product Offerings
7.7.4 LabCorp Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.7.5 LabCorp Key News
7.8 Worldwide Clinical Trial
7.8.1 Worldwide Clinical Trial Corporate Summary
7.8.2 Worldwide Clinical Trial Business Overview
7.8.3 Worldwide Clinical Trial Phase I - IV Clinical Development Services Major Product Offerings
7.8.4 Worldwide Clinical Trial Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.8.5 Worldwide Clinical Trial Key News
7.9 CROS NT
7.9.1 CROS NT Corporate Summary
7.9.2 CROS NT Business Overview
7.9.3 CROS NT Phase I - IV Clinical Development Services Major Product Offerings
7.9.4 CROS NT Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.9.5 CROS NT Key News
7.10 Dynakin
7.10.1 Dynakin Corporate Summary
7.10.2 Dynakin Business Overview
7.10.3 Dynakin Phase I - IV Clinical Development Services Major Product Offerings
7.10.4 Dynakin Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.10.5 Dynakin Key News
7.11 Rho, Inc.
7.11.1 Rho, Inc. Corporate Summary
7.11.2 Rho, Inc. Business Overview
7.11.3 Rho, Inc. Phase I - IV Clinical Development Services Major Product Offerings
7.11.4 Rho, Inc. Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.11.5 Rho, Inc. Key News
7.12 Synteract
7.12.1 Synteract Corporate Summary
7.12.2 Synteract Business Overview
7.12.3 Synteract Phase I - IV Clinical Development Services Major Product Offerings
7.12.4 Synteract Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.12.5 Synteract Key News
7.13 ICBio CRO
7.13.1 ICBio CRO Corporate Summary
7.13.2 ICBio CRO Business Overview
7.13.3 ICBio CRO Phase I - IV Clinical Development Services Major Product Offerings
7.13.4 ICBio CRO Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.13.5 ICBio CRO Key News
7.14 Sofpromed
7.14.1 Sofpromed Corporate Summary
7.14.2 Sofpromed Business Overview
7.14.3 Sofpromed Phase I - IV Clinical Development Services Major Product Offerings
7.14.4 Sofpromed Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.14.5 Sofpromed Key News
7.15 Profil
7.15.1 Profil Corporate Summary
7.15.2 Profil Business Overview
7.15.3 Profil Phase I - IV Clinical Development Services Major Product Offerings
7.15.4 Profil Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.15.5 Profil Key News
7.16 ICON Plc
7.16.1 ICON Plc Corporate Summary
7.16.2 ICON Plc Business Overview
7.16.3 ICON Plc Phase I - IV Clinical Development Services Major Product Offerings
7.16.4 ICON Plc Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.16.5 ICON Plc Key News
7.17 Clinipace
7.17.1 Clinipace Corporate Summary
7.17.2 Clinipace Business Overview
7.17.3 Clinipace Phase I - IV Clinical Development Services Major Product Offerings
7.17.4 Clinipace Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.17.5 Clinipace Key News
7.18 OCT Clinical
7.18.1 OCT Clinical Corporate Summary
7.18.2 OCT Clinical Business Overview
7.18.3 OCT Clinical Phase I - IV Clinical Development Services Major Product Offerings
7.18.4 OCT Clinical Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.18.5 OCT Clinical Key News
7.19 EPS Group
7.19.1 EPS Group Corporate Summary
7.19.2 EPS Group Business Overview
7.19.3 EPS Group Phase I - IV Clinical Development Services Major Product Offerings
7.19.4 EPS Group Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.19.5 EPS Group Key News
7.20 Beijing Sun-novo Pharmaceutical Research
7.20.1 Beijing Sun-novo Pharmaceutical Research Corporate Summary
7.20.2 Beijing Sun-novo Pharmaceutical Research Business Overview
7.20.3 Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Major Product Offerings
7.20.4 Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.20.5 Beijing Sun-novo Pharmaceutical Research Key News
7.21 Dmedglobal
7.21.1 Dmedglobal Corporate Summary
7.21.2 Dmedglobal Business Overview
7.21.3 Dmedglobal Phase I - IV Clinical Development Services Major Product Offerings
7.21.4 Dmedglobal Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.21.5 Dmedglobal Key News
7.22 WuXi AppTec
7.22.1 WuXi AppTec Corporate Summary
7.22.2 WuXi AppTec Business Overview
7.22.3 WuXi AppTec Phase I - IV Clinical Development Services Major Product Offerings
7.22.4 WuXi AppTec Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.22.5 WuXi AppTec Key News
7.23 Elixir Clinical Research
7.23.1 Elixir Clinical Research Corporate Summary
7.23.2 Elixir Clinical Research Business Overview
7.23.3 Elixir Clinical Research Phase I - IV Clinical Development Services Major Product Offerings
7.23.4 Elixir Clinical Research Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.23.5 Elixir Clinical Research Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
